• Explore /
  • Poster
  • / Phase I trial of weekly cabazitaxel with concurrent intensity-modulated radiation therapy (IMRT) and androgen deprivation therapy (ADT) for the treatment of high-risk prostate cancer (PCa).

Phase I trial of weekly cabazitaxel with concurrent intensity-modulated radiation therapy (IMRT) and androgen deprivation therapy (ADT) for the treatment of high-risk prostate cancer (PCa).

Abstract Poster

Authors

null

Jianqing Lin

The Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA

Jianqing Lin , Robert Benjamin Den , Timothy Norman Showalter , Jean H. Hoffman-Censits , Monica McGuire , Brooke Kennedy , Mark Hurwitz , Edouard John Trabulsi , Costas D. Lallas , Hushan Yang , Ruth C. Birbe , Inna Chervoneva , Adam Dicker , William Kevin Kelly

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Clinical Trial Registration Number

NCT01420250

Citation

J Clin Oncol 33, 2015 (suppl 7; abstr 26)

DOI

10.1200/jco.2015.33.7_suppl.26

Abstract #

26

Poster Bd #

B18

Abstract Disclosures

Similar Posters

First Author: Luca Faustino Valle

First Author: Rana R. McKay

First Author: Christina H. Son

First Author: Benjamin Ernst Onderdonk